Relationship between neointimal strut bridge and jailed side-branch ostial area

Xiangqi Wu1, Wei You1, Zhiming Wu1

  • 1Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Rd, 210006, Nanjing, China.

Herz
|September 27, 2019
PubMed

Insights

A short strut distance in coronary artery stenting promotes neointimal bridge formation. This bridge formation significantly impacts the side-branch ostial area one year after the procedure.

Area of Science:

  • Cardiovascular Research
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Coronary artery disease (CAD) management often involves stenting complex bifurcations.
  • Drug-eluting stents (DES) are used to treat left anterior descending (LAD)/diagonal branch (D) bifurcations.
  • Understanding neointimal hyperplasia is crucial for long-term stent patency.

Purpose of the Study:

  • To investigate the relationship between neointimal strut bridge formation and the side-branch (SB) ostial area.
  • To analyze outcomes after single DES crossover stenting in LAD/D bifurcations.
  • To evaluate the impact of neointimal bridges on SB ostial dimensions at 1-year follow-up.

Main Methods:

  • Optical coherence tomography (OCT)-guided single DES implantation in 64 coronary heart disease (CHD) patients.
  • Patients were categorized into neointimal bridge (n=20) and non-neointimal bridge (n=44) groups based on 2D OCT.
  • Analysis included clinical, angiographic, 2D/3D OCT, and DES data at baseline and 1-year follow-up.

Main Results:

  • Patients with neointimal bridges showed larger neointimal bridge area and smaller SB ostial area (p<0.01).
  • A shorter strut distance was associated with neointimal bridge formation (p<0.05).
  • Both groups exhibited decreased SB ostial lumen diameter and area post-procedure compared to pre-procedure.

Conclusions:

  • Short strut distance facilitates neointimal bridge formation after single crossover stenting.
  • Neointimal bridge formation significantly influences the SB ostial area at 1-year follow-up.
  • This finding has implications for optimizing stent placement in coronary bifurcations.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
485
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
504
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
249